These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30273388)

  • 1. The eCura system as a novel indicator for the necessity of salvage surgery after non-curative ESD for gastric cancer: A case-control study.
    Niwa H; Ozawa R; Kurahashi Y; Kumamoto T; Nakanishi Y; Okumura K; Matsuda I; Ishida Y; Hirota S; Shinohara H
    PLoS One; 2018; 13(10):e0204039. PubMed ID: 30273388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: "eCura system".
    Hatta W; Gotoda T; Oyama T; Kawata N; Takahashi A; Yoshifuku Y; Hoteya S; Nakagawa M; Hirano M; Esaki M; Matsuda M; Ohnita K; Yamanouchi K; Yoshida M; Dohi O; Takada J; Tanaka K; Yamada S; Tsuji T; Ito H; Hayashi Y; Nakaya N; Nakamura T; Shimosegawa T
    Am J Gastroenterol; 2017 Jun; 112(6):874-881. PubMed ID: 28397873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience.
    Tian YT; Ma FH; Wang GQ; Zhang YM; Dou LZ; Xie YB; Zhong YX; Chen YT; Xu Q; Zhao DB
    World J Gastroenterol; 2019 Aug; 25(29):3996-4006. PubMed ID: 31413533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting residual neoplasia after a non-curative gastric ESD: validation and modification of the eCura system in the Western setting: the W-eCura score.
    Morais R; Libanio D; Dinis Ribeiro M; Ferreira A; Barreiro P; Bourke MJ; Gupta S; Amaro P; Küttner Magalhães R; Cecinato P; Boal Carvalho P; Pinho R; Rodríguez de Santiago E; Sferrazza S; Lemmers A; Figueiredo M; Pioche M; Gallego F; Albéniz E; Ramos Zabala F; Uchima H; Berr F; Wagner A; Marques M; Pimentel-Nunes P; Gonçalves M; Mascarenhas A; Soares EG; Xavier S; Faria-Ramos I; Sousa-Pinto B; Gullo I; Carneiro F; Macedo G; Santos-Antunes J
    Gut; 2023 Dec; 73(1):105-117. PubMed ID: 37666656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal extent of lymph node dissection in patients with gastric cancer who underwent non-curative endoscopic submucosal dissection with a positive vertical margin.
    Furukawa K; Kamiya S; Sugino T; Aizawa D; Kawabata T; Notsu A; Hikage M; Tanizawa Y; Bando E; Takizawa K; Ono H; Terashima M
    Eur J Surg Oncol; 2020 Dec; 46(12):2229-2235. PubMed ID: 32788095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Additional Gastrectomy Including Endoscopic Submucosal Dissection Scar for Gastric Cancer.
    Ishida R; Kanaji S; Maehara R; Hasegawa H; Yamamoto M; Matsuda Y; Yamashita K; Matsuda T; Oshikiri T; Sumi Y; Nakamura T; Suzuki S; Kakeji Y
    Anticancer Res; 2018 Sep; 38(9):5289-5294. PubMed ID: 30194180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision to perform additional surgery after non-curative endoscopic submucosal dissection for gastric cancer based on the risk of lymph node metastasis: a long-term follow-up study.
    Lee S; Kim SG; Cho SJ
    Surg Endosc; 2023 Oct; 37(10):7738-7748. PubMed ID: 37567980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer.
    Chu YN; Yu YN; Jing X; Mao T; Chen YQ; Zhou XB; Song W; Zhao XZ; Tian ZB
    World J Gastroenterol; 2019 Sep; 25(35):5344-5355. PubMed ID: 31558878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological Examination of 81 Cases Added Gastrectomy for Early Gastric Cancer after ESD].
    Itoh N; Miyoshi T; Hikami S; Ochi F; Ujiie K; Nakamura Y; Takemura M; Yamaguchi A; Kakihara N; Ikawa O; Okano S
    Gan To Kagaku Ryoho; 2021 Feb; 48(2):248-250. PubMed ID: 33597371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Practically Modified Application of the eCura System.
    Lee S; Song JH; Park SH; Cho M; Kim YM; Kim HI; Hyung WJ
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of additional gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer.
    Makimoto S; Mushiake Y; Takami T; Shintani H; Kataoka N; Yamaguchi T; Oura S
    BMC Surg; 2022 Oct; 22(1):352. PubMed ID: 36183089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study.
    Hatta W; Gotoda T; Oyama T; Kawata N; Takahashi A; Yoshifuku Y; Hoteya S; Nakagawa M; Hirano M; Esaki M; Matsuda M; Ohnita K; Yamanouchi K; Yoshida M; Dohi O; Takada J; Tanaka K; Yamada S; Tsuji T; Ito H; Hayashi Y; Nakamura T; Nakaya N; Shimosegawa T
    Gastric Cancer; 2018 May; 21(3):481-489. PubMed ID: 28983696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy comparison between surgical resection and endoscopic submucosal dissection of early gastric cancer in a domestic single center].
    Rong L; Cai Y; Nian W; Wang X; Liang J; He Y; Zhang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):190-195. PubMed ID: 29492919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors and Timing of Additional Surgery after Noncurative ESD for Early Gastric Cancer.
    Duan K; Li D; Shi D; Pei J; Ren J; Li W; Dong A; Chen T; Zhou J
    Can J Gastroenterol Hepatol; 2022; 2022():3421078. PubMed ID: 35775069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total length of positive resection margins can predict remnant gastric cancer following endoscopic submucosal dissection.
    Ahn S; Do IG; Sohn JH; Yang HJ; Yoo CH; Kim K
    Pathol Res Pract; 2020 Nov; 216(11):153183. PubMed ID: 32919303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer.
    Toyokawa T; Ohira M; Tanaka H; Minamino H; Sakurai K; Nagami Y; Kubo N; Yamamoto A; Sano K; Muguruma K; Tominaga K; Nebiki H; Yamashita Y; Arakawa T; Hirakawa K
    Surg Endosc; 2016 Jun; 30(6):2404-14. PubMed ID: 26463497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes and risk factors of non-curative endoscopic submucosal dissection for early gastric cancer: a retrospective multicenter study in Zhejiang, China.
    Jin CQ; Zhao J; Ding XY; Yu LL; Ye GL; Zhu XJ; Shen JW; Yang Y; Jin B; Zhang CL; Lv B
    Front Oncol; 2023; 13():1225702. PubMed ID: 37854682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node metastasis can be determined by just tumor depth and lymphovascular invasion in early gastric cancer patients after endoscopic submucosal dissection.
    Goto A; Nishikawa J; Hideura E; Ogawa R; Nagao M; Sasaki S; Kawasato R; Hashimoto S; Okamoto T; Ogihara H; Hamamoto Y; Sakaida I
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1346-1350. PubMed ID: 29084076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer.
    Liang XQ; Wang Z; Li HT; Ma G; Yu WW; Zhou HC; Liu HB
    Asian J Surg; 2020 Oct; 43(10):973-977. PubMed ID: 31964584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction model for non-curative resection of endoscopic submucosal dissection in patients with early gastric cancer.
    Kim EH; Park JC; Song IJ; Kim YJ; Joh DH; Hahn KY; Lee YK; Kim HY; Chung H; Shin SK; Lee SK; Lee YC
    Gastrointest Endosc; 2017 May; 85(5):976-983. PubMed ID: 27756614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.